Therapeutics Systems Research Laboratories (TSRL), Inc. is a privately owned, specialty pharmaceutical company based in Ann Arbor, Michigan. We create value by partnering with academic researchers and entrepreneurs and providing a combination of business and scientific expertise, infrastructure, and wet-lab data to take drug-therapy concepts to business formation or licensing readiness.
Key to our strategy is our Technology Accelerator, an ongoing collaborative process that lends our expertise and capabilities to investigators seeking to obtain the data and non-dilutive funding necessary to develop and/or commercialize their inventions. Our initial focus is improving existing drug products by applying our versatile prodrug platform technologies to optimize therapy regimen for treating infectious diseases.
Potential target indications of our lead small molecule and peptide candidates include: influenza, HSV, VZV, CMV, EBV, poxvirus, HPV, Adenovirus, and RNA viruses. We are also actively scouting antibiotic opportunities to incorporate into our pipeline.